Literature DB >> 11250850

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England.

S A Shakir1, L V Wilton, A Boshier, D Layton, E Heeley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250850      PMCID: PMC26545          DOI: 10.1136/bmj.322.7287.651

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Acute myocardial infarction after the use of sildenafil.

Authors:  R R Arora; M Timoney; L Melilli
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

Review 2.  Prescription-event monitoring--recent progress and future horizons.

Authors:  R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

  2 in total
  18 in total

1.  Cardiovascular events in users of sildenafil. Paper does not provide any reassurance.

Authors:  N Dunn
Journal:  BMJ       Date:  2001-07-07

Review 2.  Clinical update on sildenafil citrate.

Authors:  Ian H Osterloh; Alan Riley
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

3.  Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients.

Authors:  James A Kaye; Hershel Jick
Journal:  BMJ       Date:  2003-02-22

Review 4.  The art and science of risk management: a US research-based industry perspective.

Authors:  Janice K Bush; Wanju S Dai; Gretchen S Dieck; Linda S Hostelley; Thomas Hassall
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  [Erectile dysfunction].

Authors:  G Ludwig; H Porst; U Wetterauer; H Sperling; U Hartmann
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 6.  Sexual activity and ischemic heart disease.

Authors:  Richard A Lange; Glenn N Levine
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

7.  [Side effects of erectile dysfunction drug treatment].

Authors:  H Sperling
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

8.  Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertension.

Authors:  Dean Patterson; Gordon T McInnes; John Webster; Malcolm M Mitchell; Thomas M Macdonald
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 9.  Cardiovascular safety of sildenafil.

Authors:  Diane Tran; Laurence Guy Howes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.